本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Teladoc Health Inc.

6.48
-0.1050-1.60%
成交量:45.53萬
成交額:295.71萬
市值:11.76億
市盈率:-6.52
高:6.56
開:6.55
低:6.44
收:6.58
52周最高:9.89
52周最低:4.40
股本:1.82億
流通股本:1.81億
量比:0.49
換手率:0.25%
股息:- -
股息率:- -
每股收益(TTM):-0.9925
每股收益(LYR):-1.1400
淨資產收益率:-12.99%
總資產收益率:-3.22%
市淨率:0.90
市盈率(LYR):-5.68

資料載入中...

2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/23

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]